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Abstract 
There is a growing need for tissue transplantations that cannot be met with current biomedical 
methods. Tissue engineering (TE) is a new interdisciplinary field that aims to construct viable tissues 
by utilizing artificial tissue scaffolds and bioreactors. To achieve this cells need to be provided with 
various stimuli that are present in their natural surroundings, the extracellular matrix (ECM). The 
most important properties of ECM are absence of cytotoxicity, biocompatibility, biodegradability 
and mechanical properties, which should be adapted in the scaffold biomaterial. Other necessary 
properties are zero risk of pathogens, versatile manufacturing and inexpensive production. Currently 
there is no such material available and thus TE is searching for new potential biomaterials, one of 
them being spider silk proteins. 
Spider silk proteins have exceptional mechanical properties, including no cytotoxic effects, 
biocompatibility and biodegradability. In addition, spider silks can be manufactured into different 
morphologies, such as fiber meshes or foams. However, cannibalistic nature of spiders and low 
production of silk protein make harvesting of native silk very inefficient. Recombinant production 
can be utilized to overcome these issues and previous research has shown that recombinant spider 
silk proteins are suitable for TE, and that the biocompatibility can be improved by introducing 
bioactive molecules to the protein structure via genetic engineering.  
Three silk like fusion proteins based on spidroin ADF3 by Araneus diadematus were produced with 
cytotoxic lipopolysaccharide free Escherichia coli strain. The silk constructs were CBM-ADF3-
CBM, CBM-ADF3-FB_H-Crys and Crys-ADF3-FB_H-Crys, where CBM is cellulose binding 
module from Ruminiclostridium thermocellum, FB_H is heparin binding site from fibronectin and 
Crys is gamma crystallin D from Homo sapiens. Cytotoxicity and biocompatibility in forms of cell 
viability and adhesion were tested with human dermal fibroblast (HDF) cultivations on silk films, 
and the results showed notable improvement in cell viability when replacing CBM with Crys. In 
addition, there was no signs of cytotoxicity. Cell adhesion was hardly improved with addition of 
binding site in CBM-ADF3-FB_H-Crys suggesting inaccessibility of the site or non-compatibility 
with HDF. Results of Crys-ADF3-FB_H-Crys were comparable with conventional material gelatin. 
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Tiivistelmä 
Kudossiirrosten kysyntä kasvaa jatkuvasti eikä nykyiset lääketieteen menetelmät kykene vastaamaan 
tähän tarpeeseen. Kudosteknologia on uusi monitieteellinen ala, jonka tavoitteena on kasvattaa 
elinkelpoisia kudoksia käyttämällä keinotekoisia tukiverkkomateriaaleja ja bioreaktoreita. Tämän 
saavuttaakseen solut tarvitsevat samankaltaisia ärsykkeitä kuin niiden luonnollisessa 
elinympäristössä, soluväliaineessa. Väliaineen tärkeimmät ominaisuudet ovat biosopivuus, 
biohajoavuus, sytotoksisuus ja mekaaniset ominaisuudet, jotka tulisivat olla myös tukiverkko-
materiaalissa. Lisäksi muita tarpeellisia ominaisuuksia ovat olematon patogeenien riski, tuotteen 
muotoilumenetelmät ja edullinen tuotanto. Tällä hetkellä vastaavaa materiaalia ei ole saatavilla, joten 
uusia lupaavia biomateriaaleja tutkitaan jatkuvasti, joista yksi on hämähäkin silkkiproteiini. 
Hämähäkin silkkiproteiineilla on erinomaiset mekaaniset ominaisuudet, ne eivät aiheuta 
sytotoksisuutta ja ovat biosopivia sekä biohajoavia. Lisäksi hämähäkin silkki voidaan valmistaa eri 
muotoihin, kuten kuituverkoksi ja vaahdoksi. Kuitenkin, hämähäkkien kannibalisminen luonne ja 
alhainen silkin tuotanto tekevät silkin keräyksestä erittäin epätehokasta. Rekombinanttituotantolla 
tuotto on skaalattavissa ja aikaisemmat tutkimukset ovat osoittaneet, että rekombinantti hämähäkin 
silkki soveltuu kudosteknologian käyttötarpeisiin, ja että biosopivuutta voi parantaa lisäämällä 
bioaktiivisia molekyylejä silkkiproteiinin rakenteisiin geenitekniikan avulla. 
Tässä diplomityössä tuotettiin kolmea silkin kaltaista fuusioproteiinia, jotka pohjautuvat ADF3 
silkkiproteiiniin (Araneus diadematus): CBM-ADF3-CBM, CBM-ADF3-FB_H-Crys ja Crys-
ADF3-FB_H-Crys, jossa CBM on selluloosakiinnitysmoduuli (Ruminiclostridium thermo-cellum), 
FB_H on solukiinnityspaikka fibronektiinistä ja Crys on gamma D krystalliini (Homo sapiens). 
Tuotto tehtiin Escherichia coli kannalla (ClearColi BL21), joka ei tuota sytotoksisia 
lipopolysakkarideja. Silkin sytotoksisuus, solukiinnitys ja -elinkelpoisuus ominaisuudet testattiin 
ihokudossolukasvatuksilla (HDF) silkkiproteiinifilmeillä. Tulokset osoittivat huomattavan 
parannuksen soluelinkelpoisuudessa, kun CBM vaihdettiin krystalliiniksi. Sytotoksisia vaikutuksia 
ei huomattu. Solukiinnitys ei parantunut oletettavasti kiinnityspaikan lisäyksessä, mikä viittaa 
epäsopivuuteen HDF:n kanssa tai paikan luoksepääsemättömyyteen. Crys-ADF3-FB_H-Crys 
tulokset olivat verrattavissa yleisesti solukasvatuksissa käytettyyn gelatiiniin. 
Avainsanat  kudosteknologia, silkki, hämähäkki, biosopivuus, fuusioproteiini, rekombinantti 
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1 Introduction 
Currently skin and organ damages can be treated with transplantation treatments, 
where the transplanted tissue originates from the same patient or from another 
individual. While these methods are widely used in medical science, they have 
major limitations such as risk of rejection, applicability for severe wounds and 
availability of enough transplants for all patients. Tissue engineering (TE) is a new 
interdisciplinary field combining knowledge from biomedical and engineering 
sciences aiming to solve these problems by constructing viable tissues with the use 
of artificial tissue scaffolds. In general, relevant cell line(s) would be seeded onto 
the artificial scaffold matrix and grown in bioreactor while providing sufficient 
stimuli for the cells until the formed tissue is fully functional and ready for 
implantation. The natural environment of the cell, extracellular matrix (ECM), can 
be investigated to get an understanding of the required properties for the scaffold 
material, and this would suggest that the most important are absence of cytotoxicity, 
biocompatibility, biodegradability and ECM-like mechanical properties, such as 
high tensile and compressive strength. Also, in engineering point of view low cost 
and versatile manufacturing are required for commercial applications. [1] 
Current scaffold materials can be divided into three groups; ceramics, synthetic 
polymers and natural polymers. While these materials are used in the biomedical 
science, all have their shortcomings; e.g. ceramics have poor biodegradability and 
limited manufacturing, synthetic polymers are not biocompatible, and natural 
materials, such as ECM extracts from mammalian cells are susceptible to pathogens 
that are difficult to detect, and tend to be expensive. Thus, TE field is searching for 
new biomaterials and many promising materials are already under development, 
one of them being spider silks. They have remarkable mechanical properties, such 
as combination of high tensile strength and elasticity, while they are also 
biodegradable and fairly biocompatible, and do not cause cytotoxic effects with 
mammalian cells. The spider silk threads are composed of silk proteins that have 
long central part with repetitions of crystalline and amorphous regions, flanked with 
small terminal domains. In silk fibers the crystalline regions form β-sheets, which 
are responsible for the mechanical strength while elasticity comes from the 
amorphous regions. The terminal units are believed to control fiber formation from 
liquid to solid. [2]–[5] 
While the spider silks have exceptional properties, production has been 
problematic. Harvesting spider silk from spiders is inefficient due to their 
cannibalistic nature and low silk thread yield. Recombinant production of different 
silk proteins has been tested with various prokaryotes and eukaryotes, such as 
Escherichia coli, Pichia pastoris and Bombyx mori cells, but long and repetitive 
sequence of spider silks causes issues with polymerase chain reactions (PCR) and 
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expression system of the hosts, especially in prokaryotes and lower eukaryotes. 
Also, spider silks are prone to aggregate and have high content of certain amino-
acids exhausting amino-acid and tRNA reserves of the host resulting in poor yields. 
If the silk is produced for biomedical uses, pathogenicity and cytotoxicity are other 
factors that affect the suitability of the host organisms; e.g. mammalian cells can 
harbor undetectable cryptic viruses and Gram-negative bacteria, such as E. coli 
release cytotoxic lipopolysaccharides (LPS) that are difficult to remove from the 
silk product. While biotechnological production of spider silk has significant 
limitations, many approaches have been implemented to overcome these issues, 
such as producing shorter spider silks, engineering of the central part and 
overexpression of bottlenecking amino-acid reserves. [5]–[8] 
Thus, recombinant spider silk proteins (RSSP) seem to be suitable for TE and some 
research has already been done on this topic. RSSP rS1/9 (94 kDa), an analogue of 
Nephila clavipes spidroin 1, was tested in vivo and in vitro studies by Moisenovich 
et al., showing good biocompatibility, biodegradability and promotion of tissue 
growth [9]. RSSPs pNSR-16 and pNSR-32 (102 and 196.6 kDa), both containing 
an Arg-Gly-Asp (RGD) cell adhesion site from fibronectin, were tested in vivo 
experiments (rat burn wound) and the results suggested suppression of 
inflammatory effects and good biocompatibility, with no significant difference to 
commercially used collagen foam [10]. RSSP 4RepCT was constructed by Stark et 
al. and it consisted of four repetitions of crystalline and amorphous regions with C 
terminal domain from major spidroin 1 of Euprosthenops australis resulting to 
length of 23.8 kDa [11]. 4RepCT was tested in vivo with rat wounds and the results 
showed good biodegradability and biocompatibility supporting growth of 
vascularized tissue, albeit with slight inflammatory effect [12]. Widhe et al. studied 
the effect of adding RGD binding site to 4RepCT and in vitro experiments showed 
notable improvement in cell adhesion and viability compared to the original 
4RepCT [13]. These results support the suitability of RSSPs in TE, and that the 
properties can be enhanced with genetic engineering. 
The aim of this thesis was to evaluate cytotoxicity and biocompatibility of silk like 
fusion proteins based on ADF3, major ampullate spidroin 1 by Araneus diadematus, 
and draw structure-function relationships between the constructs and compare them 
to conventional matrix materials. Three silk constructs were produced with 
cytotoxic LPS free E. coli strain (ClearColi BL21). The silk constructs were CBM-
ADF3-CBM, CBM-ADF3-FB_H-Crys and Crys-ADF3-FB_H-Crys, where CBM 
is cellulose binding module from Ruminiclostridium thermocellum, ADF3 is gland 
silk fibroin 3 from A. diadematus without terminal units, FB_H is heparin binding 
site from fibronectin and Crys is gamma crystallin D from Homo sapiens. Gamma 
crystallin is an extremely stable and soluble protein found in human eye nerve cells 
[14].The hypothesis was that replacing CBM with gamma crystallin increases 
biocompatibility while retaining high solubility, and addition of cell binding site 
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increases cell adhesion. Cytotoxicity of the silk constructs was tested with human 
dermal fibroblast (HDF) two dimensional (2D) cultivations. Biocompatibility with 
HDF (2D) was tested in forms of cell viability and cell adhesion with metabolic 
activity assay (MTT) and cell adhesion assay, respectively. The results were 
compared to conventional material gelatin, and structure-function relationships for 
replacement of CBM with crystallin and presence of adhesion site were studied. 
While useful, implementation of 3D scaffolds, modification of silk films with 
kosmotropic salts and additional silk constructs were beyond of the scope of this 
thesis. 
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2 Background / Literature review 
This literature review goes through some key aspects of what to consider when 
designing functionalized silk proteins for tissue engineering. The first part covers 
relevant biological background: structure of extracellular matrix, general properties 
required in scaffold materials, mammalian cell adhesion, current scaffold 
biomaterials and how to functionalize them. The second part covers spider silk 
proteins in general, previous research in spider silk functionalization and novelty of 
silk-like fusion proteins that were used in this thesis. 
2.1 Biological background 
2.1.1 Extracellular matrix and scaffold material properties 
The extracellular matrix (ECM) is a mixture of extracellular proteins secreted by 
the local cells (Figure 1). The matrix has various functions; it provides a structural 
support for the cells, contains binding domains for adhesion receptors, and binds 
soluble growth and other signaling factors. These factors affect the cell behavior, 
such as differentiation, polarity and migration of the cells. The structure and content 
of ECM varies between cell types; tendons have high ECM content while organs 
have little of it, and epithelial rich areas tend to have highly vascularized ECM that 
contain mostly collagen I while basement membrane contain typically collagen IV, 
laminin and entactin. [15], [16] 
The ECM proteins are generally large and complex, and contain repeats of different 
highly conserved domains [15]. While the domains can be found in other protein 
families, the arrangement of the domains are unique to ECM proteins. This can be 
used to identify ECM proteins from protein databases resulting in a list of proteins 
that comprises 1-1.5% of mammalian proteome. Main components of the list are 
glycoproteins (~200), collagen subunits (43) and proteoglycans (~40). [17] 
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Figure 1. Extracellular matrix (ECM) with attachments to cell. Main components 
of ECM are glycoproteins, proteoglycans and collagens. Cells attach to ECM via 
integrins. Modified from: [18]. 
Glycoproteins are proteins that contain one or more oligosaccharide chains. The 
oligosaccharide chains are generally relatively short and branched, and attached 
covalently to a side chain of the protein during post-translational modification.  The 
sugar chains have various effects on the protein, such as making it more resistant to 
proteases, assisting in folding, and modifying antigenic and functional properties. 
ECM glycoproteins have multiple functions, such as ECM assembly, binding 
growth factors, cell adhesion and signaling. The most well-known and abundant 
glycoprotein is fibronectin, which is composed of two large subunits that are linked 
with sulfide bonds. It has binding sites for cells, matrix fibers, various signaling 
factors, and it can serve as a linkage between other ECM proteins and cell 
membrane via cell adhesion sites. The most well-known cell adhesion site in 
fibronectin is RGD tripeptide (Arg-Gly-Asp), which is often used in 
functionalization of scaffold biomaterials. In addition, fibronectin has complex 
functions, such as shifting from soluble to insoluble fibers between cells and ECM 
when under tension, and containing buried integrins that are only available after 
digested by proteases. [17], [19] 
The structural strength of ECM is provided by collagens, which can be divided into 
two sub-groups by their ability to form fibrils; fibrillar and non-fibrillar collagens. 
Formations of different collagens vary significantly, but they are all recognized by 
the presence of three polypeptide chains (α chains), and a tripeptide motif Gly-X-
Y, X and Y being any amino acid. In a typical collagen, the three α chains contain 
numerous repetitions of the tripeptide motif, which allow the chains to form triple-
helical structures (Figure 2). These triple-helical structures form micro fibrils that 
bundle into collagen fibers. The most abundant fibrillar collagen is collagen I, 
which is found in wide variety of cell types, such as tendon and vasculature. It has 
two identical α chains and one distinct α chain, each chain consisting around 340 
repeats of Gly-X-Y, flanked by short non-helical regions. Unlike many other 
collagens, the repeats are mainly uninterrupted resulting in rigid triple helix 
formation with higher tensile strength. The most well-known non-fibrillar collagen 
is collagen IV, which is mainly found in basement membranes alongside with 
laminin and entactin. Collagen IV has interruptions in its Gly-X-Y repeats making 
it flexible, and it forms an open network -like structure that connects with other 
membrane components. [17], [20] 
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Figure 2. Collagen fiber structure. Core components of collagen are three different 
polypeptide chains (α chains) that form triple-helical structures, which crosslink 
with each other bundling into collagen micro fibrils. Modified from: [21]. 
Like glycoproteins, proteoglycans are also proteins with one or more sugar side 
chains. The difference is that significant fraction of the side chains are unbranched 
glycosaminoglycans (GAG), which are large and highly charged polysaccharides. 
GAGs tend to occupy huge volume relative to their mass, and bind cations creating 
osmotic pressure allowing ECM to endure compressive forces. The side chains can 
contribute up to 95% of the protein’s total weight, resulting in massive molecules. 
Certain GAGs can also bind to growth factors, collagen and various glycoproteins. 
[17], [19] 
In summary, ECM is a complex mixture of proteins, which all play some part in 
providing suitable living conditions for the cells. Thus, designing one polymer to 
mimic ECM is far from trivial, but it is possible to target the most important 
properties present in ECM. The obvious properties shown in this chapter are 
mechanical properties, such as structural strength of collagen and compressive 
strength of GAGs, and biocompatibility from adhesion sites, growth and other 
signaling factors. Another property is cytotoxicity meaning that the material is not 
toxic and it is not recognized as foreign, which would cause inflammatory effect 
and potentially be rejected by the cells. Also, biodegradability is important allowing 
the cells to degrade the matrix if needed. Considering in vivo use of scaffold 
materials, slow continuous degradation to non-harmful components would be 
preferred. Finally, porous matrix with sufficient pore size is desirable to allow 
thorough migration of cells. [22] Thus, the structure of the material needs to 3-
dimensional, such as fiber mesh or foam, and its pore size should be controllable 
with different fabrication methods. Out of the given properties biocompatibility is 
the most complex, and while ideally all of the signals should be provided, it is more 
realistic to target the most important and well-known attributes. Thus, often cell 
adhesion is the first attribute to be enhanced. 
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2.1.2 Cell adhesion 
Cell adhesion is fundamental for multicellular organisms as the cells must cohere 
to keep the organized multicellular structure intact. The attachments affect 
development of the structure by controlling orientation and behavior of the cell’s 
cytoskeleton. There are cell-cell and cell-ECM junctions, and while both are 
important when considering formation of functional tissue, cell-ECM is focused 
here to provide short introduction on cell adhesion sites at ECM. [19] 
Cell-ECM junction occurs between an adhesion receptor at cell membrane and a 
ligand at ECM. The adhesion receptors are transmembrane proteins that belong to 
two transmembrane superfamilies; cadherins and integrins, which are mainly 
responsible of cell-cell and cell-ECM anchoring junctions, respectively. Thus, 
integrins and their respective ligands are in high interest when investigating 
potential mammalian cell adhesion sites. Integrins consist of α- and β- 
transmembrane protein subunits (Figure 3), which have small cytoplasmic domains 
linking to cytoskeleton of the cell and large extracellular domains attaching to ECM 
ligands or other counter-receptors at the interface of the α- and β-subunit. 24 
different α-β integrin combinations formed from 18 α and 8 β subunits have been 
identified in mammalian genomes as of 2006. Most integrins bind to wide variety 
of ligands with different affinities and vice versa; e.g. tripeptide RGD ligand found 
in fibronectin is known to bind to at least 8 integrins. Other RGD containing 
proteins can compete with fibronectin in cell adhesion and even just the RGD 
tripeptide without other amino-acids can bind to integrins. However, not all proteins 
with RGD sequence mediate cell attachment. The site can be buried inside the 
folded protein or present in non-compatible form, and thus inaccessible to integrins. 
Also, the presentation of the RGD sequence affects the affinity to different 
integrins; e.g. large fibronectin fragments with RGD bind with high affinity to α5β1 
integrin while smaller ones are preferred by vitronectin receptor αVβ3 integrin. [19], 
[23], [24] 
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Figure 3. Integrin in unligated state. Integrins are composed of α- and β- 
transmembrane protein subunits that have cytoplasmic, transmembrane and 
extracellular domains. The yellow layer is cell membrane. Modified from: [25]. 
While RGD is the most well-known adhesion site, it is not necessary always the 
best choice for functionalization of scaffold materials. RGD has been noted to 
require much higher surface densities to achieve similar binding properties 
compared to other more specific ligands. New adhesion sites can be identified with 
advanced methods such as surface arrays with self-assembling peptide monolayers. 
It can test wide variety of adhesion sites with different surface densities 
simultaneously. For example heparin adhesion sites FHRRIKA and 
GWQPPARARI were identified with surface array and both were noticed to 
mediate binding to human embryonic cells with better properties than RGD. [26], 
[27] 
2.1.3 Current biomaterials & functionalization 
Biomaterials are defined as materials that interact with biological systems and 
influence their biological processes with the aim to regenerate functional tissue. The 
current biomaterials can be divided into three groups: ceramics, synthetic materials 
and natural materials. The properties of the groups are summarized in Table 1, and 
some materials with United States Food and Drug Administration (FDA) or similar 
approval are given as an example. In addition to these groups, blends of different 
groups can be used to tailor the properties, e.g. natural ECM polymers tend to have 
poor mechanical properties, which can be reinforced with synthetic polymers that 
by themselves lack the bioactivity. [1] 
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Table 1. Biomaterial groups with some materials as an example. 
Group Material Pros Cons Ref. 
Ceramic Hydroxyapatite Biocompatibility (bone 
tissue), 
mechanical properties, cheap 
Limited fabrication, 
poor degradation, 
limited use 
[1] 
 
Bioglass 45S5 
(collagen blend) 
Biocompatibility (bone 
tissue), 
mechanical properties, 
proteolytic degradation 
Limited fabrication, 
limited use, 
expensive, pathogen 
risk 
[28] 
Synthetic 
polymer 
Polyglycolide, 
polylactides 
Mechanical properties, 
cheap, fabrication, hydrolytic 
degradation 
Biocompatibility, 
acidic degradation 
[29] 
 
Polydioxanone Cheap, fabrication, 
hydrolytic degradation, 
monofilament sutures 
Biocompatibility, 
acidic degradation, 
low modulus 
[29] 
Natural 
polymer 
(ECM 
extract) 
Collagen Natural biocompatibility, 
proteolytic degradation 
Mechanical 
properties, 
expensive, batch-to-
batch variation, 
pathogen risk 
[1], 
[30] 
 
Gelatin  
(partially 
hydrolyzed 
collagen) 
Natural biocompatibility, 
proteolytic degradation, 
strong hydrogels 
 
Mechanical 
properties, 
fast degradation, 
batch-to-batch 
variation,  pathogen 
risk 
[30] 
 
Matrigel  Excellent natural 
biocompatibility,  
proteolytic degradation 
Mechanical 
properties, 
very expensive, 
batch-to-batch 
variation,  pathogen 
risk, fabrication 
[31] 
Natural 
polymer 
(non-
ECM) 
Alginate, chitosan 
(polysaccharides) 
Mechanical properties 
(decent), biocompatibility, 
proteolytic degradation, 
cheap 
 
[32], 
[33] 
 
Silk worm silk 
(protein) 
Mechanical properties 
(excellent), biocompatibility, 
proteolytic degradation 
(slow), easy functionalization 
Structure formation 
not well understood 
[34] 
 
Ceramics, such as hydroxyapatite and tri-calcium phosphate, have high mechanical 
stiffness, low elasticity and brittle surface. Ceramics have been mainly used in 
orthopedics due to their compatibility with bone tissue: they share chemical and 
structural similarities with native bone, which allows good interaction with 
osteogenic cells enhancing their differentiation and proliferation. However, the 
major disadvantages are negligible biodegradation with exception of a few 
bioceramics, and limited fabrication. [1] Biological properties have been improved 
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by blending biodegradable hydroxycarbonate (bioglass) with bioactive natural 
polymer collagen. The combination is called Bioglass 45S5, which has been used 
in over million bone defect surgeries. [28] 
Synthetic polymers, such as certain polymerized forms of lactic acid (polylactide), 
have good mechanical properties and low production costs, and the architecture of 
the scaffold is highly controllable. Most of the synthetic polymers are degradable 
via chemical hydrolysis and not affected by cell-triggered proteases. Thus, 
degradation does not vary between patients, which is often preferred over the 
randomness of natural degradation. However, chemical hydrolysis of many 
synthetic polymers, such as poly-l-lactic acid (PLLA) and polyglycolide (PGA), 
form carbon dioxide as a byproduct of degradation that lowers the pH of its 
surroundings inducing necrosis. Unlike ceramics and natural polymers, 
biocompatibility of the synthetic polymers tends to be very low, which leads to poor 
interaction with cells and increases the chance of inflammatory response. 
Nevertheless, many synthetic polymers, such as PGA, polylactides and 
polydioxanone have been widely used in less demanding surgical treatments (e.g. 
sutures). [1], [22], [29] 
Natural polymers refer to polymers that are produced in nature, and thus the group 
contains wide range of possible materials with different properties. The major 
subgroup of natural polymers with biomedical applications is animal derived ECM 
extracts, such as collagen from animal skins and Matrigel, mixture of ECM proteins 
from mouse sarcoma cells. Generally ECM extracts have very favorable biological 
properties including natural biodegradation rate and exceptional biological activity 
that promotes cell interactions. The downsides are batch-to-batch variations, 
difficult fabrication, insufficient mechanical properties for load-bearing 
applications, too rapid and uncontrollable degradation for some applications and 
expensive production. In addition, major problem with animal derived cell extracts 
are risk of pathogens since they can harbor cryptic viruses and other undetectable 
diseases that can infect the patient. Nevertheless, the superior biological properties 
outweigh the downsides and ECM extracts are the current go to choice for many 
tissue engineering applications. To avoid risk of pathogens, some recombinant 
ECM proteins can be produced with prokaryotes and lower eukaryotes, e.g. 
collagen has been produced with bacterial host, albeit with some difficulties in 
large-scale production due to absence of eukaryotic post-translational modification. 
Non-ECM natural polymers such as chitosan, alginate and silk worm silk (fibroin) 
have been designed to excel in areas that are lacking in ECM extracts. They are 
generally easy produce without batch-to-batch variation and fabricate into different 
morphologies, cheap and have decent mechanical properties, but compared to ECM 
extracts the biological activity is mediocre at best. The use of alginate, chitosan and 
fibroin have been approved for some surgeries by FDA. [1], [22], [33]–[35] 
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2.1.4 Functionalization of biomaterial 
Biomaterials can be functionalized by adding bioactive domains to enhance 
biocompatibility and other biological properties. Commonly used techniques for 
altering surface of biomaterial are physical adsorption, covalent immobilization and 
encapsulation. In physical adsorption biomaterial is dipped in liquid containing 
bioactive molecules which adhere onto the biomaterials driven by their affinities. 
This can be enhanced by increasing the wettability of the biomaterial, but since 
adsorption is based on weak interactions, the method is inefficient and the bioactive 
molecules can diffuse rapidly when the surrounding medium is changed. In 
encapsulation bioactive molecules are encapsulated inside the biomaterial and 
released slowly to the medium while protecting the capsulated molecules from 
degradation, which is especially useful in drug carrier applications. Covalent 
immobilization can be used to induce a strong coupling between functional groups 
of the biomaterial and bioactive molecule, such as carboxylic and amine group. 
Other reactive functional groups needs to be protected prior to the immobilization, 
followed by removal of the protection, which might affect biological activity of the 
materials. Also, the method has poor controllability and with multiple functional 
groups the exact coupling locations cannot be pre-determined. However, by using 
recombinant proteins and gene engineering it is possible to design the protein-based 
biomaterial to contain various bioactive domains at specific locations, and it would 
eliminate the need of chemical treatments. The DNA sequence of protein 
biomaterial is fused with DNA of the bioactive molecule, and the new DNA is 
inserted to an expression system, produced and purified. There are limits to this 
method since modification of the biomaterial can have various unwanted effects, 
such as incorrect protein folding, disruption in biomaterial matrix structure, 
inaccessibility of the bioactive molecule or poor production yield. [36], [37] 
Some already tested strategies in functionalization of protein-based biomaterials are 
addition of ligands for integrins, such as RGD and REDV peptides to enhance cell 
adhesion and recognition sites for proteases to improve biodegradability. Other 
possible modifications are addition of antimicrobial domains to prevent bacteria 
adhesion, binding domains for certain ions e.g. calcium for teeth implants, and 
fusion with full or fragments of bioactive proteins, such as fibronectin and various 
growth factors. [36], [37] For synthetic materials physical adsorption and 
encapsulation are often easier to implement than covalent immobilization. As an 
example biocompatibility of synthetic polymer PCL has been enhanced by 
dissolving bioactive heparin into water and then mixing it with methanol and DCM. 
This solution was loaded to PCL matrix, which showed positive results in 
preventing binding of unwanted cell types, without causing inflammatory response. 
[38] 
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2.2 Spider silk and its functionalization 
Spiders have the ability to produce a variety of silk threads suitable for different 
purposes, such as weaving elastic webs for catching prey and strong safety lines to 
escape predators. The silk threads are composed of proteins and each silk type has 
unique mechanical properties. Dragline silk that is used in web frames and safety 
lines is known to have exceptional tensile strength and elasticity, and thus it has 
been the main focus in spider silk research. The silk dope is produced in the glands 
of the spider, and the major ampullate gland is responsible of dragline silk 
production (Figure 4). The protein components of dragline silk, spidroins, are 
formed in epithelial cells located in the glands tail and partly in the sac (purple area 
in Figure 4) and secreted into the sac. Spidroins are stored there in soluble form at 
very high concentrations (up to 50 %-w/v) and they are converted into solid fibers 
via phase separation in the funnel and spinning duct (grey area in Figure 4). During 
the conversion water and chaotropic ions, sodium and chloride, are extracted and 
simultaneously kosmotropic ions potassium and phosphate are added, which also 
increases acidity from neutral pH to below pH 6. One major enzyme in this process 
has been identified to be carbonic anhydrase that extracts water and lowers pH by 
catalyzing conversion of CO2 and H2O to H
+ and bicarbonate (HCO3
-). In addition, 
spider pulls the silk thread from the end of the spinning duct, spinneret, applying 
mechanical stress on the silk dope in the spinning duct, which is believed to induce 
formation of orientated fibers, together with the change of pH and other ionic 
concentrations. [5], [39] 
 
Figure 4. Major ampullate gland (a), with schematic version including 
approximated pH values (b). Spidroins are secreted in the purple part and the silk 
dope is converted from liquid to insoluble fibers in the grey area. Modified from: 
[39]. 
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Dragline silks are mainly composed of two silk proteins; major ampulla spidroins 
(MaSP) 1 and 2. They are structurally similar consisting of long repetitive central 
part (>200 kDa) with hydrophobic polyalanine motifs and amorphous hydrophilic 
glycine-rich segments, and non-repetitive terminal domains. In silk fibers 
polyalanine blocks form β-sheets that stack into crystalline regions resulting in high 
tensile strength while extensibility of the fibers comes from the amorphous regions. 
Due to this combination, dragline silk can absorb exceptional amount of energy 
before deforming (toughness) exceeding other man-made materials, such as Kevlar. 
The non-repetitive C- and N-terminal domains are assumed to assist in formation 
of proper fibers from liquid silk dope and both domains are highly conserved in 
MaSPs indicating their necessity. [3], [40] 
In addition to exceptional mechanical properties of spidroins, they have also been 
shown to exhibit favorable properties in vivo and in vitro experiments, e.g. 
supporting regeneration of peripheral nerves, suggesting absence of cytotoxicity 
and sufficient biocompatibility. Also, silk fibers are susceptible to some 
mammalian proteases, such as chymotrypsin that cleaves the amorphous regions 
allowing slow degradation in vivo. Silk proteins have been shown to lose their 
tensile strength in one year and disintegrate in two years in vivo. Furthermore, 
spider silk can be processed into different morphologies, such as hydrogels, films 
and fiber meshes. In case of recombinant spider silk proteins (RSSP) the mechanical 
properties can be tuned by altering the conversion from liquid silk dope to fiber, 
and the biotechnological production is scalable allowing production of large 
quantities with reasonable prices compared to mammalian derived ECM-proteins 
without risk of pathogens. Thus, spider silk fulfils the requirements for scaffold 
material that were mentioned previously. [3], [4], [41], [42]  
Compared to currently used biomaterials, spidroins are very similar with sericin-
free fibroins, with the exception of better mechanical properties. Polysaccharide-
based non-ECM natural polymers are cheaper to produce, but lack the ease of 
functionalization and mechanical properties. ECM extracts have better 
biocompatibility, but are much more expensive, difficult to fabricate, include risk 
of pathogens and batch variation, and have inferior mechanical properties. While 
ceramic implants seems to be quite different, the macromolecules of native bone 
are mainly composed of collagen network (~30 % of bone mass) [43]. Thus, the 
network could be replaced with spidroin mesh and mineralized with hydroxyapatite 
nanoparticle crystals resulting in bone implants with improved load-bearing 
properties [43]. Synthetic polymers can achieve mechanical properties close to 
spidroins [29] and they are cheaper to produce. However, they lack 
biocompatibility, targeted functionalization and natural degradation. Thus, spider 
silk seems to be a very promising biomaterial, but some major issues still needs to 
be solved. Conversion from liquid silk dope to solid fiber is not well understood 
preventing RSSP fibers achieving similar mechanical properties with native 
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dragline silk, and more advanced biocompatibility is required for formation of 
functional tissue both in vitro and in vivo. [3], [4] 
There has been some previous research on functionalization of RSSP. Various cell 
binding sites have been tested with different RSSPs. Stark et al.  constructed a short 
RSSP (23.8 kDa) 4RepCT that consisted of four repetitions of crystalline and 
amorphous regions with C terminal domain from major spidroin 1 of 
Euprosthenops australis [11]. Widhe et al. studied the effect of adding RGD 
sequence from fibronectin type III module 10 to 4RepCT with three different 
versions; XTGRGDSPAX, where the X’s were replace with cysteines (FNCC), 
valine and serine (FNVS), and serines (FNSS). RGD with two cysteines were 
assumed to form disulfide bond resulting in a hairpin loop resembling the structure 
of RGD in native fibronectin, and the other two conformations were used as 
controls. Early cell adhesion (1 hour) to the silk films was tested with endothelial 
cells, mesenchymal stem cells and keratinocytes. RGD silk films promoted cell 
adhesion compared to the unmodified 4RepCT and FNCC showed significant 
improvement to other RGD silk film, indicating the importance of the conformation 
of RGD. [13] Wohlrab et al. studied addition of GRGDSPG to eADF4 RSSP. The 
modification did not affect secondary structure, water contact angle or surface 
toughness of the silk films, and cell adhesion to BALB/3T3 mouse fibroblasts was 
significantly improved [44]. The same material was used by Schaht et al. to produce 
hydrogel (3 %-w/w) and the RGD modified version showed significant 
improvement in cell adhesion with all tested cell lines (fibroblast, myoblast, HeLa 
cell, osteoblast, and keratinocyte). In addition, they tested 3D printing of hydrogels 
seeded with fibroblasts, which showed sufficient viability, albeit slightly lower than 
commonly used alginate. However, the mechanical properties of the silk hydrogel 
was better than the alginate, which requires toxic thickeners and crosslinkers to be 
printable. [45]  
In drug carrier research receptor binding peptides H2.1 and H2.2 were added to 
15mer RSSP MS1 to aid in targeting cells overexpressing growth factor receptor 
Her2, which is typical for tumor tissue. The RSSP and binding peptides retained 
their functions, and the functionalized RSSP spheres were shown to target tumor 
cells, albeit with some unspecificity. The spheres were loaded with cancer drug 
(doxorubicin) and showed pH dependent release. [46] Jansson et al. added small 
affinity domains (6-17 kDa) for IgG (Z and C2), albumin (ABD) and biotin (M4) 
to 4RepCT RSSP. All domains showed affinity to their corresponding targets 
indicating proper folding and accessibility, and they did not hinder silk assembly 
progress. While the study was not related to biomedical science, it shows that it is 
possible to fuse RSSP with moderately sized protein domains without losing 
properties of the silk or the fused protein. [47] 
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In the present study three silk like fusion proteins based on native ADF3 were used; 
CBM-ADF3-CBM, CBM-ADF3-FB_H-Crys and Crys-ADF3-FB_H-Crys. The 
previous studies showed that it is possible to enhance biocompatibility of RSSP by 
introducing cell adhesion sites, and that small proteins (~20 kDa) can be added 
without hampering properties of the fused protein or RSSP. However, there has not 
been prior biomedical research on RSSP with native ADF3 or its analogue eADF3, 
and the heparin binding site has not been used with other than hES cells [26]. 
Biocompatibility and cytotoxicity of ADF3 and compatibility of the heparin 
binding site with human dermal fibroblasts are addressed in this study. Moreover 
this study presents preliminary results of humanization of silk protein with human 
proteins as terminal domains.  
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3 Materials and methods 
Important methods and materials for the experimental part will be explained in this 
section in chronological order.  
3.1 Spider silk constructs 
Three different fusion proteins were used in the cell culture experiments (Figure 5): 
CBM-ADF3-CBM, CBM-ADF3-FB_H-Crys and Crys-ADF3-FB_H-Crys. The 
fusion proteins were designed by Sesilja Aranko, and the expression plasmids were 
assembled by Ellinor Englund. The central part was a major ampulla gland silk 
fibroin 3 (ADF3) from Araneus diadematus (Uniprot Q16987) without the terminal 
domains (43 kDa), which has been codon optimized for E. coli. The terminal 
constructs were cellulose binding module (CBM) (17.3 kDa) from 
Ruminiclostridium thermocellum and gamma crystallin D (Crys) (20.3 kDa) from 
Homo sapiens, and they were attached to ADF3 by linker peptides. The peptide 
sequence FB_H was a nine amino-acids long heparin binding site found in 
fibronectin (sequence GWQPPRARI). All fusion proteins contained a histidine tag 
(H6) for affinity purification. 
 
Figure 5. Silk like fusion proteins. ADF3 = native gland silk fibroin 3 from Araneus 
diadematus without terminal units. CBM = cellulose binding module from 
Ruminiclostridium thermocellum. Crys = gamma crystallin D from Homo sapiens. 
FB_H = heparin binding site from fibronectin. L = linker for terminal domains. 
H6 = histidine tag. 1= CBM-ADF3-CBM, 2 = CBM-ADF3-FB_H-Crys, 3 = Crys-
ADF3-FB_H-Crys. 
3.2 ClearColi BL21, transformation and preparation of glycerol stocks 
ClearColi BL21 (DE3) strain by Lucigen was used in production of the spider silk. 
The difference to normal E. coli BL21 (DE3) is that it has modified LPS, lipid IVA, 
which does not contain oligosaccharide chains and has only four acyl chains instead 
of six (Figure 6). Removal of oligosaccharide chains makes it easier to remove the 
LPS in purification steps. Inflammatory effect of endotoxin comes from recognition 
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of the six acyl chains by Toll-like receptor 4 (TLR4), and with four acyl chains lipid 
IVA does not trigger endotoxic response in mammalian cells. Thus, there is no need 
for extensive washing steps to remove endotoxin from the product or quantification 
of endotoxicity with LAL endotoxin assays. The downside is approximately 50 % 
slower growth rate of normal E. coli BL21 (DE3). [48] 
 
Figure 6. Lipopolysaccharide of ClearColi BL21 and normal E. coli BL21. Grey 
components are saccharides (O polysaccharide), red components are glucosamine 
residues flanked with phosphate groups (white sphere), and the chains are acyl 
chains. Modified from: [48]. 
Electrocompetent ClearColi BL21 (E. coli) cells were transformed with plasmids 
containing expression cassette for the previously mentioned silk constructs and 
antibiotic resistance for kanamycin according to Lucigen’s transformation protocol. 
25 μl of electrocompetent cells were thawed and pipetted to an ice-cold 
electroporation cuvette with 0.1 mm gap. 1 μl of around 10 ng/μl plasmid DNA was 
added, and it was mixed by flicking the cuvette. After a few minutes, the cells were 
electroporated with 1.8 kV (unknown capacity, and immediately 975 μl of 
Expression Recovery Medium at room temperature (RT) was added in the cuvette. 
The mixture was pipetted to a 10 ml culture tube, and incubated in 37 °C 200 rpm 
for 1 hour. 10-100 μl of the cell mixture was plated on a LB-Miller or LB-Lennox 
plate containing 50 μg/ml kanamycin, and incubated for 1-2 days in 37 °C. After 
overnight incubation the colonies were small with diameter less than 1 mm. There 
was no significant difference noticed in growth speed between LB-Miller and LB-
Lennox. [48] 
Preparation of glycerol stocks for long-term storage was initially done by 
inoculating 5 ml LB-Lennox (50 μg/ml kanamycin) with transformed ClearColi 
strain and incubated over 6 h in 37 °C 200 rpm, as suggested by Lucigen. 500 μl of 
the cell broth was mixed with 500 μl sterile 25 % glycerol and flash freezed with 
liquid nitrogen before storing in -80 °C. However, this was noted to result in poor 
stocks that were difficult to revive. With OD600 measurements it was apparent that 
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liquid cell culture inoculated from a plate had a long lag time (4-6 h) until proper 
growth. Thus, preculture (LB-Miller with 50 μg/ml kanamycin) was inoculated with 
a transformed colony and it was incubated overnight 37 °C 220 rpm. 500 μl of the 
preculture was moved to 5 ml LB-Miller with 50 μg/ml kanamycin, and incubated 
till OD 0.6-0.8 (~3-4 h), which was mixed with glycerol and stored as previously 
explained. [48] 
3.3 Silk protein production with E. coli 
Precultures were generally conducted by inoculating 100 ml LB containing 50 
μg/ml kanamycin with ClearColi glycerol stock, and incubated overnight in 37 °C 
220 rpm. Precultures were diluted in 1 L of LB with kanamycin resulting in 0.1 
OD600. In the first four production batches cultures were incubated in 37 °C 220 
rpm for 24 h, and LB-Lennox was used as a media. In the following batch 
incubation time was reduced to 2-3 h for the culture to reach 0.6-0.8 OD, and media 
was changed to LB-Miller, which increased product yields significantly. Cultures 
were induced with 0.2 mM IPTG, and incubated in 30 °C 220 rpm for 24 h. 
The cells were harvested by centrifuging 18700 rcf 20 min RT, and lysed by 
incubating in 100 ml lysis buffer (50 mM TRIS-HCL pH 7.4, 3 mM MgCl2, 
DNase-A, lysozyme, 1 tablet of SigmaFast protease inhibitor cocktail) / 2 L culture 
for 40 minutes 200 rpm in RT. The cells were erupted with EmulsiFlex C3 
homogenizer. Soluble silk protein was harvested by centrifuging 25000 rcf for 2 h 
in RT and collecting the supernatant. Supernatant was flash freezed with liquid 
nitrogen and stored in -80 °C. 
3.4 Fast protein liquid chromatography 
The silk proteins were separated from the lysis supernatant with fast protein liquid 
chromatography (FPLC) (ÄKTA pure by GE Healthcare), which separates 
components according to their affinity to the column material. Silk protein 
constructs contained His-tags, which have high affinity to nickel. During FPLC the 
lysis supernatant was injected in the nickel column that binds to proteins with His-
tag. The column was washed with buffer solution to remove impurities that had low 
affinity to nickel. The column was eluted with gradually increasing concentration 
of imidazole, which at certain point released the His-tag protein due to imidazole’s 
higher affinity to nickel. Elution of proteins were seen as a spike in UV 280 nm 
detector located in downstream. 
Three 5 ml His-Tag columns were used, and 100 ml of supernatant was loaded per 
one run. Binding buffer was 20 mM imidazole, 500 mM NaCl, pH 7.4, and elution 
buffer 500 mM imidazole, 500 mM NaCl, pH 7.4. Phosphate was not added in the 
buffers as it was noticed to aggregate silk proteins. Eluted products were flash 
freezed with liquid nitrogen and stored in -80 °C. 
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3.5 Concentration and washing of silk protein 
The eluted silk protein solution were initially washed from imidazole, salt and other 
impurities with Econo-Pac gravity-flow chromatography column by adding 3 ml 
lysis supernatant and then 5 ml TRIS-HCl while collecting the flow-through. 
However, due to the loss of product and significant time investment, this washing 
step was only done with the first two silk protein batches. 
Concentration and additional washing was done with 20 ml Vivaspin 30 kDa 
protein concentrator spin columns. Each sample (10-50 ml) was concentrated to 
volume of 5 ml by centrifuging 3500 rcf 30 °C. The concentrate was washed three 
times with 15 ml sterile 50 mM TRIS-HCl pH 7.4, and concentrated to volume of 
0.5-1.5 ml, both with the previous centrifuge settings. The final concentrate was 
filtered with 0.20 μm filter, and the protein concentration was measured with 
Nanodrop. 
3.6 SDS-PAGE 
SDS-PAGE was used to detect the presence of the silk constructs and estimate the 
amount other protein contaminants or degraded silk proteins in the silk 
concentrates. The separation and stacking gel were done according to Table 2 with 
9 and 5 % acrylamide content, respectively. Both gel solutions were incubated for 
40 minutes RT. Protein samples were denatured and dyed by using 4X loading dye 
with DTT and incubating for 5 minutes in 92 °C. Generally 20 μl of 2 mg/ml 
denatured protein solution was added in the wells. 5 μl of Bio-Rad’s Precision Plus 
Protein Dual Color Standard (10-250 kDa) was used as the ladder, and the gel was 
ran with 80V until proteins passed the stacking gel and then the voltage was 
increased to 100V. The gel was stained with Coomassie Blue for overnight and 
destained with destaining solution (42.5 % ethanol, 10 % acetic acid) for 2 hours, 
both in RT with 180 rpm shaking. Imaging was done with Gel Doc XR (BioRad). 
Table 2. Preparation of gel solutions for SDS-PAGE. 
 
Separating gel Stacking gel 
H2O 3,19 ml 2.57 ml 
TRIS-HCl 2.25 ml (1.5 M, pH 8.8) 437 μl (1 M, pH 6.8) 
APS 95.14 μl 33,3 μl 
SDS (10 %) 95.14 μl 33,3 μl 
TEMED 3.71 μl 3,3 μl 
Acrylamide (40 %) 2,25 ml 437 μl 
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3.7 Production of silk films 
Two methods were used to form spider silk films. In the first method liquid silk 
concentrate was spread evenly on a glass coverslip, and it was incubated in RT until 
the liquid was completely evaporated, generally overnight, in sterile conditions. 
100-150 μl of 2-3 mg/ml silk concentrate was added on a glass slide with diameter 
of 22 mm, resulting in around 0.08 mg/cm2. 
When moving to smaller sample areas such as 96-well plates, more convenient 
method was required. Thus, 50-100 μl of 0.3 mg/ml silk concentrate was added per 
well and incubated 2 h RT. The remaining solution was aspirated and the plate was 
incubated overnight RT in laminar. Similar method was used by Widhe et al. in “A 
fibronectin mimetic motif improves integrin mediated cell biding to recombinant 
spider silk matrices”. [13] 
3.8 Fibroblast cell culturing 
Human dermal fibroblast (HDF) isolated from adult skin (Gibco™ C0135C) was 
used for the cytotoxicity and biocompatibility tests. HDF is a robust and adherent 
cell type that is found in dermis of skin embedded in ECM. It is a dynamic cell 
lineage capable of changing its phenotype according to different stimuli from ECM, 
and the presence of surface that it can adhere onto is necessary for its survival. Thus, 
HDF is suitable for the preliminary tests. It can also be induced into a pluripotent 
stem cell line for further research. HDFs can produce ECM components to its local 
surroundings, and it is the main producer of ECM components in healing 
wounds. [49] Thus, it is possible that it can alter its surroundings even in the test 
conditions giving better results for the scaffold materials. 
Mammalian cultures are susceptible to many contaminations due to their slow 
growth, favorable media and lack of antibiotics, and thus good aseptic technique 
was essential part of cultivating fibroblasts. The cultures were always handled in 
Class II Biological Safety Cabinet with HEPA filtered laminar airflow dedicated 
purely to mammalian cells. Tools were sterilized with 70 % ethanol before moving 
them to the laminar, and only sterile reagents were used. Gloves and clean 
laboratory coat were always worn. 
Normal culturing of HDF was done in a plastic petri dish coated with gelatin. 10 ml 
of sterile 0.1 % gelatin was added in a petri dish, and incubated for 20 min in RT. 
The remaining solution was aspirated and the dish was dried for 10 min. 20 ml of 
HDF growth media (Cell Applications, Inc.) at 37 °C was pipetted in the dish. The 
dish was seeded with 105-106 fibroblasts from a cryostock or trypsinated cells from 
previous culture. If cryostock was used, it was thawed in water bath 37 °C until a 
small bit of ice was left and then promptly pipetted in the dish. With trypsinated 
cells around 0.5-2.0 ml of the cell mixture was used for seeding. The petri dish was 
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mixed by swirling gently to spread the cells evenly and then moved in a CO2 
incubator (37 °C, 5 % CO2). The media was changed daily by aspirating old media 
and adding 20 ml of fresh HDF growth media (37 °C) slowly to the side of the dish. 
In some cases 100X antibiotic cocktail containing 10000 U/ml penicillin and 10000 
μg/ml streptomycin was used by adding 10 μl cocktail per 1 ml of media. 
Continuous usage of antibiotic is not recommended as it masks poor aseptic 
technique and thus potentially exposing the culture to other contaminations, such 
as yeast, mycoplasma and antibiotic resistant bacteria. 
Subculturing and preparation of cryostocks were done according to the provider’s 
(Sigma-Aldrich) protocol [50]. The culture was grown to 70-90 % confluency, 
taking typically 3-5 days. The dish was washed with sterile PBS (37 °C) to remove 
cell clumps and trypsin inhibiting media. 3 ml of Trypsin-EDTA was added, and 
the dish was incubated up to 5 minutes while rocking and hitting the side of it every 
one minute to assist in releasing the bound cells. During incubation the dish was 
inspected with microscope to see if the cells had turned into spheres, indicating 
successful trypsination. Trypsin was inhibited by adding 6 ml Dulbecco’s Modified 
Eagle Medium (DMEM), and the solution was collected to a Falcon tube. The dish 
was washed with 5 ml of DMEM, and pipetted to the Falcon tube to collect the 
remaining cells. Inhibition of trypsin should not be delayed as it damages the cells 
due to its proteolytic activity. The cell density of the cell mixture was analyzed with 
Countess II FL Automated Cell Counter by Invitrogen. For subculturing, the cell 
mixture was used for the seeding. For cryostock preparation, the cell mixture was 
centrifuged 220 rcf 4 °C for 5 minutes. The supernatant was aspirated and the cell 
pellet was resuspended in Recovery Freezing Medium by Gibco containing 10 % 
dimethyl sulfoxide (DMSO), and pipetted in 0.5-1 ml aliquots to cryovials. The 
cryovials were frozen with controlled rate (~1 °C/min) by placing them in an 
isopropanol bath, which was stored in -20 °C for 2 hours and then moved to -80 °C 
for overnight. For long term storage the cryovials were moved to -150 °C without 
the isopropanol bath. During preparation and revival of cryostocks the cells are 
exposed to DMSO, which makes the cell membrane porous protecting it from 
thawing, but it is also detrimental to the viability of the cell [51]. This was noticed 
during the experiments; with prolonged preparation the fibroblast cryostocks were 
unable to revive, which was prevented by minimizing the exposure time from over 
1 hour to 10 minutes. 
3.9 Microscopy 
Leica microscope with 10X lens was used to examine fibroblast cultures; e.g. 
possible contaminations, estimate confluency and recognize dead or unattached 
cells. The microscope was not used to create statistically good quantitative data 
about amount of cells or viability, as it was too time consuming to get a sufficient 
representative of each sample. The microscope also included a camera (Leica DFC 
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3000 G with software Leica LAS X) and a fluorescence illuminator (Leica 
CoolLED's pE-300white).  
3.10 DAPI staining 
To ease the counting of the cells, DAPI (4,6-Diamidino-2-Phenylindole) was used 
to stain the nuclei of the cells. After cultivation of the sample, e.g. a seeded well in 
12-well plate, it was washed three times with PBS (37 °C) and the cells were fixated 
with 8 minute incubation in 4 % polyformaldehyde (PFA) in PBS at RT. The 
washing step (3x) was repeated and the cells were permeabilized with 8 minute 
incubation in 0.1 % Triton X-100 in PBS at RT, and washed three times. The cells 
were stained with 1 μg/ml DAPI in PBS for 5 minutes at RT in dark, and washed 
twice. The samples were then imaged with fluorescence camera with 400 nm 
excitation and 460 nm emission. Without fixation and permeabilization DAPI 
staining of live cells was noted to be very poor. Initially it was planned that the 
fluorescence would be measured with a plate reader (Cytation 3 BioTek), and then 
compare the results between the samples. However, the readings were close to zero 
in all samples. 
3.11 Cell viability analysis with MTT 
In most cells mitochondrial activity is associated with cell viability, and thus NADH 
level can be used to roughly estimate cell viability. MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide) oxidizes NADH inside the cells forming 
purple formazan, which can be dissolved and measured with absorbance at 540 and 
720 nm. Unlike staining and counting the cells, MTT gives more homogenous 
measurement resulting in better quantitative data about cell viability. [52] 
MTT assay was performed with 96-well plates that were coated with different 
scaffold materials as explained in 3.2.5. The plate was seeded with 100 μl/well of 
HDF media containing 105-106 trypsinated fibroblasts/ml. The plate contained 
control wells (bovine serum albumin (BSA), gelatin) and blank wells (without 
cells). Minimum of three technical replicates were used for each scaffold material 
and each set of samples were seeded with the same amount of cells to keep the 
results comparable. The plate was incubated in a CO2 incubator (37 °C, 5 % CO2) 
for 1-2 days and the media was changed daily. For estimating the cell viability 10 
μl of 5 mg/ml MTT in PBS was added to one set of samples and incubated for 4 
hours in a CO2 incubator. The media was aspirated and the formazan crystal were 
dissolved by adding 100 μl DMSO/well and incubating for 5 minutes in RT inside 
aluminum foil. The plate was read with an Eon BioTek plate reader by setting the 
protocol to 567 cpm (3 mm) linear shake for 1 minute, 10 second delay and measure 
absorbance at 570 nm. 570 nm was used instead of 540 nm due to more repeatable 
measurements. If the plate contained multiple sample sets, the DMSO was removed 
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and the plate was put back to the CO2 incubator. All pipetting was done with a 
multichannel pipette to reduce variability due to pipetting errors. 
3.12 Cell adhesion assay 
In addition to cell viability, cell adhesion plays important part in evaluation of 
scaffold material biocompatibility. The assay was done in 96-well plates that were 
coated with scaffold materials as explained in 3.2.5, with control wells (gelatin, 
BSA) and blank wells (without cells). The wells were seeded with 100 μl HDF 
media containing 1x106 trypsinated fibroblasts / ml and incubated in a CO2 
incubator (37 °C, 5 % CO2) for 3 hours. The wells were washed three times with 
PBS (37 °C) to remove unattached cells. The cells were fixed by incubating in 4 % 
PFA for 8 minutes at RT, and washed once with PBS. The staining was done with 
Crystal Violet by pipetting 70 μl/well of 0.5 % Crystal Violet in 25 % methanol and 
incubating for 10 minutes at RT. Crystal Violet was washed with tap water by 
gently pouring it over the plate. The plate was turned upside down and dried for 1 
hour at RT with vacuum evaporation. Crystal Violet was dissolved by incubating 
with 200 μl methanol per well for 30 minutes at RT, and the absorbance was 
measured at 570 nm with an Eon BioTek plate reader. Protocol for the measurement 
was set to 567 cpm (3 mm) linear shake for 1 minute, 10 second delay and measure 
absorbance at 570 nm. 
3.13 Structural analysis of silk films 
Measurement of contact angle and Fourier-transform infrared spectroscopy (FTIR) 
were used for structural analysis of the silk films. The silk films for contact angle 
measurement were prepared on clear polystyrene surface (downside of 96-well 
plate and upside of a petri dish lid) by adding 50 μl of 0.3 mg/ml protein solution 
and letting it incubate for 2 hours at RT with or without cover. Without cover the 
solution evaporated completely resembling the method 1 in 3.7. After incubation 
with a cover, the remaining solution was aspirated to mimic coating in method 2. 
In both methods the films were kept in laminar for overnight at RT. The 
measurements were done with Attension Theta (Biolin Scientific). The injected 
amount of deionized water varied from 0.5 to 2.0 μl. In cases where the droplet 
formed an asymmetrical shape, a new droplet was injected, since the angle was not 
uniform at all sides.  
FTIR detects molecular vibrations of stretching and bending chemical bonds. The 
resulting data can be used to determine the structure of the sample; e.g. C=O 
stretching coupled with in-plane N-H bending can be seen as a strong peak in region 
1600-1700 cm-1. This is called amide I band in protein IR, and the exact location of 
the peak changes when it originates from α-helices or β-sheets. Thus, the location 
of the amide I can be used to draw conclusions about the secondary structure of the 
protein. Other structural sensitive bands are amide II-VII. However, quantitative 
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estimation of secondary structure is often not trivial and requires additional tools 
such as pattern recognition algorithms for the results to be reliable. Also, the peak 
location for a certain secondary structure, such as α-helix, is not necessary the same 
for different proteins, thus making comparison of secondary structure difficult. [53] 
Here the IR spectra was only used to draw conclusion about the structural 
differences between silk fusion proteins without specifying where it originates 
from. IR measurement of silk films was done with PerkinElmer Spectrum 2 FT-IR 
Spectrometer by adding 5 μl of 5 mg/ml protein solution on the diamond lens and 
evaporating it for at least 40 minutes. The IR spectra was normalized with Spectrum 
software by dividing each absorbance value with the highest peak absorbance.  
3.14 Scanning electron microscope 
Scanning electron microscope was used briefly to image the cells adhering to the 
silk films for qualitative data, but due to rough sample preparation all of the cells 
had been disrupted. The HDF cultures on glass slides were washed with PBS and 
fixed with increasing gradient of formaldehyde (FA) from 4 to 10 % in steps of 2 
with 10 minute incubation at RT. It should be noted that the FA (formalin) 
contained around 10 % methanol to prevent the polymerization of the FA. Methanol 
dehydrates the cells rapidly which can affect the morphology of the cell by 
shrinking it. The samples were stored in 4 % FA at 4 °C. Prior to SEM imaging, the 
samples were doused in liquid nitrogen and dried in vacuum evaporator for 
overnight. The samples were sputtered with platinum and imaged with SEM. 
With the previous protocol the cells were disrupted and thus a gentler sample 
preparation was needed. In SEM sample preparation aimed for biological samples 
the cell samples on glass slides were washed with PBS (37 °C) and fixed with 2.5 % 
glutaraldehyde in PBS for 30 minutes at RT. The samples were then dehydrated by 
adding an increasing alcohol gradient using 25, 40, 60, 80, 90 and 100 % ethanol, 
each step with 15 minute incubation at RT. Ethanol was evaporated by using a 
desiccator for minimum of 30 minutes. [54] However, the samples were not imaged 
due to lack of time. The assumption is that this method would be more suitable for 
delicate cell samples. 
3.15 Statistics 
One-way analysis of variance (ANOVA) was used to compare expected values of 
the sample groups and find significant differences. The null hypothesis (H0) of 
ANOVA is that all samples come from the same distribution. Assumptions are that 
the samples are independent and identically distributed (IID), the variances of the 
populations are equal and the residuals are normally distributed. Violation of these 
assumptions leads to unreliable results; especially IID and homogeneity of 
population variances are crucial for ANOVA to work properly. ANOVA produces 
F-statistics, which is used to determine if H0 is rejected. Here significance level (α) 
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0.05 was used. If p-value for F-statistics falls below α, H0 is rejected. In such cases 
Tukey’s Post Hoc Test was used to find significant difference between individual 
sample groups. It compares expected values between all sample pairs with H0 that 
they come from the same distribution, and performs p-value correction so that the 
probability of rejecting one or more true H0 is less than α for all comparisons. 
Tukey’s test has the same assumptions as ANOVA. Assumptions about normality 
and equality of variances were tested with Shapiro-Wilk’s and Bartlett’s test, 
respectively (𝛼 =  0.05). If equality of variances did not hold, Welch’s t-test with 
Bonferroni’s p-value adjustment was applied instead of ANOVA / Tukey. 
However, with low sample size the power of these statistical analyses is poor, and 
the results should be considered with caution. In some cases unequal sample sizes 
were used, which is not beneficial for statistical analyses as the power is determined 
by the lowest sample size. 
Bar plots were used for graphical visualization with error bars set to be plus/minus 
the standard deviation (SD) indicating the spread of the data. When assuming 
normality, the error bar estimates the location of 66 % of the population. Standard 
deviation was chosen instead of standard error, which shows the accuracy of the 
calculated mean, because variance is also an important result together with the 
mean.  
All data analysis was done with R programming language by using open source 
software RStudio.  
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4 Results 
4.1 Production of silk like fusion proteins 
The silk constructs were produced in five batches with varying results. The yields 
from 1 liter of culture are shown in Figure 7, and comparison of product quality 
between batch 4 and 5 after FPLC purification in Figure 8. The expected size of 
CBM-ADF3-CBM, CBM-ADF3-FB_H-Crys and Crys-ADF3-FB_H-Crys were 85 
kDa, 85-88 kDa and 88 kDa, respectively. Thus, the wide bands in the protein gel 
were in the right locations. The smaller bands were assumed to be truncated silk 
proteins as they remained after FPLC purification. The production was optimized 
between batches 4 and, which could be seen in both yield and quality of the silk 
proteins. 
 
Figure 7. Yield (mg) of silk constructs from 1 L of cell culture (ClearColi BL21). 
The protocol was changed between batch 4 and 5, which can be seen in yield 
improvement. 
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Figure 8. SDS-PAGE: Comparison of product quality between batch 5 (left) and 4 
(right) after FPLC purification. 1 and 5 = CBM-ADF3-CBM. 2 and 6 = CBM-
ADF3-FB_H-Crys. 3 and 7 = Crys-ADF3-FB_H-Crys. 4 = ladder. Expected sizes 
for complete silk constructs 85-88 kDa. Other bands are assumed to be truncated 
silk constructs. 
4.2 Initial evaluation of cytotoxicity 
Evaluation of cytotoxicity of the silk constructs was done with 12-well cultivations 
and coated glass slides as explained in chapters 3.7 and 3.8. In the first experiment 
majority of the wells were contaminated on day 1, including wells with uncoated 
glass slides. Initially no antibiotic was used, but addition of streptomycin and 
penicillin cocktail did not seem to be effective, thus indicating antibiotic resistance. 
The unknown organism had bacillus like shape and was often in diplobacilli form 
resembling E. coli, which would not be surprising as antibiotic resistant E. coli 
strains were commonly used in the laboratory. It was concluded that the 
contamination originated from non-sterile glass slides, and thus in the next 
experiments the glass slides were dry sterilized in 160 °C for minimum of 2 hours. 
The cell cultures were imaged with SEM for qualitative data and some of the images 
can be found in attachments (Attachment 1, Attachment 2 and Attachment 3). 
However, all of the cells were exploded indicating too harsh preparation method. 
The protocol for fixation and evaporation were changed to be more suitable for 
biological samples. In the second cytotoxicity experiment the HDF cryostocks did 
not revive. This was caused by incorrect preparation of the cryostocks that resulted 
in prolonged exposure of cells to DMSO. DMSO is used in cryopreservation but it 
is also toxic to cells at high concentrations [51]. The preparation method was 
changed to minimize the exposure time, which solved the problem. 
The third experiment was successful. During seven-day cultivation there was no 
notable difference in growth between the silk films, uncoated glass (control), BSA 
and conventional matrix material gelatin. Images from 5th day of cultivation with 
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10X microscope before and after DAPI staining are presented in Figure 9, Figure 
10, Figure 11, Figure 12 and Figure 13. Multiple images were taken from each 
sample, but only representative images are shown here. CMB-ADF3-FB_H-Crys 
and Crys-ADF3-FB_H-Crys contained notable amount of aggregates.  
 
Figure 9. Evaluation of cytotoxicity: Fibroblast culture on glass surface after 5 days 
of incubation with (left) and without (right) DAPI staining. 
 
Figure 10. Evaluation of cytotoxicity: Fibroblast culture on gelatin film after 5 days 
of incubation with (left) and without (right) DAPI staining. 
 
Figure 11. Evaluation of cytotoxicity: Fibroblast culture on CBM-ADF3-CBM film 
after 5 days of incubation with (left) and without (right) DAPI staining. 
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Figure 12. Evaluation of cytotoxicity: Fibroblast culture on CBM-ADF3-FB_H-
Crys film after 5 days of incubation with (left) and without (right) DAPI staining. 
 
Figure 13. Evaluation of cytotoxicity: Fibroblast culture on Crys-ADF3-FB_H-
Crys film after 5 days of incubation with (left) and without (right) DAPI staining. 
4.3 Cell viability 
The initial idea was to estimate cell viability by counting the amount of cells daily 
in cultivations with coated glass slides (12-well). However, it was quickly noted 
from the cytotoxicity tests that the cell density was not uniform and the results from 
cell counting differed considerably between different locations on the same sample. 
For meaningful quantitative results, there should have been multiple cell counts 
from each sample on daily basis, and with three technical replicates of six sample 
types this was not reasonable. DAPI staining was tested for automated cell counting 
but the plate reader (Cytation 3 BioTek) did not recognize the fluorescence of 
DAPI. It is possible that the settings given for the instrument were wrong or the 
placement of the sample was off due to unusual height. To solve this the optimal 
excitation and emission of DAPI could have been verified and optimized with 
fluorescence spectra analyzer and glass slides measured individually without the 
12-well plate. However, it was noted by our colleague that the fluorescence 
measurement is taken from a single point, and scanning of larger area could not be 
implemented. Thus, homogeneous measurement was not possible to achieve with 
this method.  
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MTT was chosen for more convenient method for estimating the cell viability. It 
measures the concentration of NADH in the cells, which is an indication of 
mitochondrial activity [52]. Three MTT tests were conducted. In the first test too 
low amount of cells were seeded due to insufficient knowledge and error in 
calculations or in cell counter. The aimed seeding level was 500 cells / well. 
However, there were maximum of 20 cells / well (96-well plate), and they divided 
very slowly in all of the samples. The MTT results from 5 days old cultures did not 
differ between blanks and samples. The test was repeated with higher seeding 
amount, and two seeding levels were tested; 10 000 and 50 000 cells/well with three 
technical replicates. The results are shown in Figure 14 and Figure 15 for day 1, 
and Figure 16 and Figure 17 for day 2 measurements. 
  
Figure 14. MTT (cell viability assay) test 2 on day 1 with low cell seeding (10 000 
cells/well). Control is from uncoated wells. Gelatin and BSA are used as 
conventional materials. Significance levels are denoted with different letters (a, b, 
c) on top of error bars. Letters shared in common between samples indicate no 
significant difference (ANOVA/Tukey Post Hoc, p-value < 0.05). Error bar ± 1 SD. 
Sample size 3. 
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Figure 15. MTT (cell viability assay) test 2 on day 1 with high cell seeding (50 000 
cells/well). Control is from uncoated wells. Gelatin and BSA are used as 
conventional materials. Significance levels are denoted with different letters (a, b, 
c) on top of error bars. Letters shared in common between samples indicate no 
significant difference (ANOVA/Tukey Post Hoc, p-value < 0.05). Error bar ± 1 SD. 
Sample size 3. 
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Figure 16. MTT (cell viability assay) test 2 on day 2 with low cell seeding (10 000 
cells/well). Control is from uncoated wells. Gelatin and BSA are used as 
conventional materials. Significance levels are denoted with different letters (a, b, 
c) on top of error bars. Letters shared in common between samples indicate no 
significant difference (ANOVA/Tukey Post Hoc, p-value < 0.05). Error bar ± 1 SD. 
Sample size 3. 
 
 
Figure 17. MTT (cell viability assay) test 2 on day 2 with high cell seeding (50 000 
cells/well). Control is from uncoated wells. Gelatin and BSA are used as 
conventional materials. Significance levels are denoted with different letters (a, b, 
c) on top of error bars. Letters shared in common between samples indicate no 
significant difference (ANOVA/Tukey Post Hoc, p-value < 0.05). Error bar ± 1 SD. 
Sample size 3. 
MTT test was repeated to verify that the results were repeatable. In the third test 
40 000 cells were seeded per well and the sample size was increased to 6 for control, 
BSA and gelatin, and 8 for silk constructs (Figure 18 and Figure 19). While the 
results had the same trend as in the previous test, the absorbance level was same for 
day 1 and 2 measurements, and BSA and CBM-ADF3-CBM gave negative 
absorbance on day 2 indicating total loss of cells. This could be caused by the 1 
minute shaking (567 cpm) during day 1 measurement as all the samples were on 
the same 96-well plate.  
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Figure 18. MTT (cell viability assay) test 3 on day 1. Control is from uncoated 
wells. Gelatin and BSA are used as conventional materials. Significance levels are 
denoted with different letters (a, b, c) on top of error bars. Letters shared in common 
between samples indicate no significant difference (ANOVA/Tukey Post Hoc, p-
value < 0.05). Error bar ± 1 SD. Sample size 6 for control, gelatin, BSA, and 8 for 
silk constructs. 
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Figure 19. MTT (cell viability assay) test 3 on day 2. Control is from uncoated 
wells. Gelatin and BSA are used as conventional materials. Significance levels are 
denoted with different letters (a, b, c) on top of error bars. Letters shared in common 
between samples indicate no significant difference (ANOVA/Tukey Post Hoc, p-
value < 0.05). Error bar ± 1 SD. Sample size 6 for control, gelatin, BSA, and 8 for 
silk constructs. 
4.4 Cell adhesion 
Cell adhesion on the silk constructs was tested with adhesion assay. In the first test 
around 100 000 cells were seeded per well (Figure 20). The actual amount was 
unknown due to unreliable measurement by the cell counter, but assumedly the 
concentration was much higher than displayed by the cell counter. The experiment 
was repeated with lower cell density (70 000 cells/well) to verify repeatability 
(Figure 21). The samples had very different variances, which in result led to low 
probability of equal population variances. Thus, Welch’s t-test with p-value 
adjustment was used instead of ANOVA / Post Hoc Tukey’s test. CBM-ADF3-
FB_H-Crys in test 2 had many outliers lowering the probability of coming from 
normal distribution below 5 % preventing from using conventional statistical 
analysis methods. While variety in variances could be a meaningful result, here the 
cause was most likely non-systematic washing step for removing excess Crystal 
Violet from the samples. 
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Figure 20. Cell adhesion test 1 Control is uncoated well. Gelatin and BSA are 
conventional materials. Significance levels are denoted with different letters (a, b, 
c, d) on top of error bars. Letters shared in common between samples indicate no 
significant difference (Welch’s t-test and Bonferroni p-value adjustment, p-value 
< 0.05). Error bar ± 1 SD. Sample size 12 for control and gelatin, and 16 for BSA 
and silk constructs. 
 
Figure 21. Cell adhesion test 2. Control is uncoated well. Gelatin and BSA are 
conventional materials. Significance levels are denoted with different letters (a, b, 
c, d) on top of error bars. Letters shared in common between samples indicate no 
significant difference (Welch’s t-test and Bonferroni p-value adjustment, p-value 
< 0.05). CBM-ADF3-FB_H-Crys unlikely to be from normal distribution. Error bar 
± 1 SD. Sample size 14. 
4.5 Structural analysis of silk films 
4.5.1 Contact angle 
Contact angle (CA) measurements were done to get some idea about the surface 
properties of the silk films, and possibly make a rough comparison about the amount 
of protein in the films according to hydrophilicity. The silk and control films were 
prepared on downside of 96-well plate by adding 50 μl 0.3 mg/ml protein solution 
and incubating it overnight at RT. The CA measurements are shown in Figure 22. 
Controls and CBM-ADF3-CBM showed expected behavior, but CBM-ADF3-
FB_H-Crys and Crys-ADF3-FB_H-Crys gave much higher angle than bare 
 36 
 
polystyrene surface. The experiment was repeated with two film preparation 
methods as explained in chapter 3.13: with ventilation to mimic the previous CA 
test and without ventilation to mimic the process of coating a well in 96-well plate 
(Figure 23).  
 
Figure 22. Water contact angle of silk films, test 1. Films were prepared on 
polystyrene surface by incubating 50 μl of 0.3 mg/ml protein solution overnight at 
room temperature with ventilation. Volume of water droplet in contact angle was 
0.5-2 μl.  
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Figure 23. Water contact angle of silk films, test 2. Films were prepared on 
polystyrene surface with two methods; 50 μl of 0.3 mg/ml protein solution was 
incubated for 2 hours at room temperature without ventilation (lid closed), 
remaining solution was aspirated and then incubated overnight at room temperature, 
and with ventilation (lid open) where no liquid was aspirated. Volume of water 
droplet in contact angle was 0.5-2 μl. 
4.5.2 Fourier-transform infrared spectroscopy 
Results from FTIR are presented in Figure 24, and the recognized peak values in 
Table 3. Individual graphs can be found in attachments (Attachment 4, Attachment 
5 and Attachment 6). Three protein structure sensitive bands were recognized as 
amide I (1610-1695 cm-1), II (1480-1575 cm-1) and III (1220-1320 cm-1). Band at 
1045 cm-1 is likely from TRIS (buffer) since absorption of C-N in RNH2 gives band 
at 1030-1230 cm-1 and the three primary alcohols in TRIS exactly at 1050 cm-1. 
Similarly, IR spectra of TRIS measured by Tan et al. had a high peak at around 
1050 cm-1 [55]. This could be verified by measuring the spectra of the buffer. Water 
molecules give a wide band at 3000-3500 cm-1, which overwhelms possible 
structural bands in that region, such as amide A and B. [53], [56] 
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Figure 24. FTIR spectra of the silk constructs. Absorbances have been normalized. 
Recognized structural peaks: amide I ~1640 cm-1, amide II ~1520 cm-1, amide III 
~1250-1240 cm-1. Other peaks: water 3500-3000 cm-1 and TRIS ~1045 cm-1. 
 
Table 3. FTIR peak values of silk constructs. 
Silk construct Amide III Amide II Amide I Unknown 
CBM-ADF3-CBM 1636.7 1515.1 - 1055.3 
CBM-ADF3-FB_H-Crys 1638.5 1517.5 1245.0 1058.5 
Crys-ADF3-FB_H-Crys 1638.6 1518.2 1243.5 1058.6 
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5 Discussion 
In this thesis three silk constructs were produced with cytotoxic LPS free E. coli 
strain (ClearColi BL21): CBM-ADF3-CBM, CBM-ADF3-FB_H-Crys and Crys-
ADF3-FB_H-Crys. Cytotoxicity and biocompatibility in forms of cell viability and 
adhesion were tested with HDF cultivations on silk films and controls (gelatin, 
BSA, uncoated wells). The hypothesizes for structure-function relationships were 
that replacing CBM with gamma crystallin increases biocompatibility without 
lowering solubility, and addition of cell binding site increases cell adhesion. As 
seen in the results, cell viability did follow the hypothesis while cell adhesion did 
not. In addition, structures of different protein films were analyzed with FTIR and 
contact angle measurements, which did show structural similarities and surprisingly 
very hydrophobic water contact angles. 
5.1 Production of silk like fusion proteins 
The yield (Figure 7) and quality (Figure 8) of different batches indicate that 
induction earlier at log growth phase improved the yield of all three silk constructs 
at least by three fold, and reduced degradation of the silk. The improvement could 
also originate from media change from LB Lennox to Miller, but separate growth 
tests did not show any notable difference in OD600 between the two media. 
However, production with the optimized method has not been repeated and it is 
unknown if similar yields could be achieved again. The yield of CBM-ADF3-CBM 
is notably lower than the other two silk constructs, which could have been caused 
by many different factors, such as inefficient production of double CBM construct. 
Effect of gamma crystallin in solubility of the silk construct cannot be determined 
from these results, but the replacement of CBM with crystallin did have positive 
effect on the production yield. For further improvement in product yields, different 
IPTG concentrations and incubation times or EnPresso expression media could be 
tested. Genetic modifications, such as overexpressing tRNA pools are very time 
consuming to implement, and for small production batches of different silk 
constructs it would unlikely to save time. 
5.2 Initial evaluation of cytotoxicity 
The presented data (Figure 9, Figure 10, Figure 11, Figure 12 and Figure 13) lacks 
good quantitative properties. Counting cells from several small areas can lead to 
considerable errors since the cells are not evenly distributed. Thus, methods such 
as fluorescence assisted cell sorting should have been used for better quantitative 
data. Also, the images were taken from the end of the cultures and there is no proper 
data from the early cultures. Nevertheless, the HDF growth tests did not show 
notable cytotoxicity from the three silk constructs. While this was mostly expected 
due to previous research on spider silks [9]–[13], [44], [45] and origin of ɣ 
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crystallin, there has not been much research on cytotoxicity of cellulose binding 
module with exception of one study about binding bioactive molecules to cellulose 
via CBM, where the authors did not notice cytotoxic effects from CBM [57]. 
Surprisingly, no research was found on cytotoxicity of native ADF3 or its analogue 
eADF3. Due to the positive results, it was possible to move to viability and cell 
adhesions tests. It should be noted that the serum in culture mediums can mask 
negative effects of the matrix [58], e.g.  poor cell adhesion or cytotoxicity, and thus 
cell culture tests should be done in serum-free medium to avoid false positive 
results. 
5.3 Cell viability 
All of the MTT results follow the same trend; the silk constructs show improvement 
in viability when moving from CBM terminal domains to ɣ-crystallin, although 
there is no significant difference between CBM-ADF3-CBM and CBM-ADF3-
FB_H-CBM. In comparison to control, BSA and gelatin, Crys-ADF3-FB_H-Crys 
supported similar or a bit higher cell viability than gelatin while BSA and CBM-
ADF3-CBM were on the same level with each other. Control (uncoated wells) had 
high variety between the measurements for unknown reason, but overall it could be 
considered to be similar with BSA and CBM-ADF3-CBM. Gelatin is hydrolyzed 
collagen, which is the primary component of the ECM type that is habited by 
fibroblasts. Collagen contains functional groups and adhesion domains suitable for 
HDF that are likely to be present in gelatin [59]. Thus, it is very promising for Crys-
ADF3-FB_H-Crys to support as good or even higher cell viability than gelatin. 
However, the results did not exclusively come from NADH level of individual cells. 
During experiments it was noticed that the density of properly adhered cells prior 
to MTT staining had very high effect on the result and there was no notable 
difference in absorbance between similar cell densities. Thus, the MTT result was 
coupled with cell adhesion and it is possible that it completely outweighed the 
difference in amount of NADH in individual cells. This does not make the 
experiment meaningless as the results can still be used to evaluate the overall cell 
viability in the scaffold material, which is dominated by the capacity of supporting 
cell attachment and growth. In addition, similar correlations with viability assay 
absorbance and adhered cells were found in other articles [13], [60]. 
5.4 Cell adhesion 
The cell adhesion results from both tests (Figure 20 and Figure 21) were very 
similar. Of the three silk constructs Crys-ADF3-FB_H-Crys achieved highest 
values while CBM-ADF3-CBM and CBM-ADF3-FB_H-Crys were close to each 
other. The hypothesis was that the addition of fibronectin binding site would show 
notable improvement in cell adhesion, which was not seen here. The results 
indicated that the binding site was not accessible at least in CBM-ADF3-FB_H-
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Crys. Accessibility of the site in Crys-ADF3-FB_H-Crys could be tested by 
repeating the assay with additional silk construct Crys-ADF3-Crys. Alternatively, 
it is possible that the binding site was not compatible with HDF. The research group 
that identified the binding site tested it with human embryonic stem cells and no 
literature was found on fibroblast adhesion to it [26]. Still, considering that the cells 
were not able to adhere onto the uncoated polystyrene wells, all of the silk 
constructs did show significant increase in cell adhesion. 
Since the MTT result was noted to be tied with cell adhesion, it was surprising for 
gelatin to show better cell adhesion than Crys-ADF3-FB_H-Crys, indicating that 
the MTT result was not completely overwhelmed by adhesion properties as 
suggested earlier. BSA was found to be non-adhesion protein that can be used as an 
additive in some adhesion protein coatings (gelatin, fibronectin) [61], [62]. Thus, 
poor adhesion on BSA was not surprising, but it also did not give any additional 
information, and could be left out in further experiments. 
5.5 Structural analysis of silk films 
The water contact angle results (Figure 22 and Figure 23) were roughly repeatable 
with the exception of CBM-ADF3-CBM CA decreasing from 54 degrees to 21. 
Silks constructs CBM-ADF3-FB_H-Crys and Crys-ADF3-FB_H-Crys achieved 
very high CA (113.0°-130.5°) with both preparation methods, while CA of CBM-
ADF3-CBM and BSA changed significantly with different preparation method. 
With BSA the change assumedly came from low amount of protein in the films, as 
there was barely any difference to CA of polystyrene and the BSA films were very 
difficult to see. However, in CBM-ADF3-CBM there seemed to be very 
fundamental structural changes. The results would suggest that the high 
hydrophobicity came from ADF3 as all silk construct did achieve high CA, and at 
least in case of CBM-ADF3-CBM it was possible to alter the hydrophobicity to 
hydrophilicity by changing the preparation method of the film. It is unknown what 
could cause the change in CA or the high CA in silk films. One explanation could 
be that the hydrophobic alanine blocks of ADF3 stacked at the surface forming a 
hydrophobic layer, which could have been caused by evaporation of water forcing 
hydrophilic (amorphous) regions to group together. 
High CA with water is associated with charged surface chemistry and/or surface 
morphology. 90° contact angle with water is considered hydrophobic and 150° as 
superhydrophobic. High hydrophobicity is unusual in natural biomaterials, and thus 
synthetic biomaterials are often used in biomedical applications that require 
hydrophobicity. Cells have been shown to prefer rough surfaces, but there is no 
clear connection between surface chemistry and cell adhesion and proliferation. 
Some authors have noted enhancement of biocompatibility when increasing 
hydrophobicity while other authors have reported the opposite reaction, which 
indicates that different cell types prefer surfaces with particular hydrophobicity (/-
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philicity). [63], [64] Since it is unknown how the surface morphology behaves when 
wetted with culture medium, it is not possible to draw accurate structure-function 
relationships between cell adhesion and surface morphology or chemistry from just 
the CA of dry film with water droplet. It can be said that there is no notable 
connection between CA of dry film and cell viability or adhesion. It should be noted 
that the films were unlikely to be homogeneous, and there could have been air 
pockets on the surface affecting its properties.  
The silk films were analyzed with FTIR (Figure 24), and amide I, II and III peaks 
were identified. Evaluation of α-helix or β-sheet content was not done here as it 
would require more in-depth analyzation in order to explain structural relationship 
with amide band peak locations. Still, the results indicate that the three silk 
constructs had very similar structures. Crys-ADF3-FB_H-Crys and CBM-ADF3-
FB_H-Crys gave almost identical spectra while CBM-ADF3-CBM had lower 
(relative) amide I and II intensity and no notable amide III peak. This could have 
been caused by the absence of ɣ-crystallin, rather than difference in secondary 
structure of ADF3. The peak shifts of amide bands I, II and III (Table 3) were very 
small between the silk constructs and possibly within the resolution of the FTIR 
instrument, which also supports similarity of the secondary structures. [53], [56]  
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6 Conclusion 
Three silk like fusion proteins, CBM-ADF3-CBM, CBM-ADF3-FB_H-Crys and 
Crys-ADF3-FB_H-Crys, with central unit spidroin ADF3 by A. diadematus were 
produced with cytotoxic LPS free E. coli strain, and purified with FPLC. The 
purified silk protein concentrates were used to coat glass slides and polystyrene 
wells for cytotoxicity and biocompatibility tests, respectively. Cytotoxicity tests 
were performed with over week long HDF cultivations. Biocompatibility with HDF 
was tested in forms of cell viability and cell adhesion with two day MTT 
experiments and four hour cell adhesion assays, respectively. Controls for all 
previous experiments were uncoated well, BSA and gelatin. The structures of the 
silk films were analyzed with FTIR and contact angle measurements with water on 
coated polystyrene surface. 
The silk protein production protocol was optimized to increase the yield and in the 
final batch yields 6.5 mg/L, 15.2 mg/L and 15.3 mg/L were achieved for CBM-
ADF3-CBM, CBM-ADF3-FB_H-Crys and Crys-ADF3-FB_H-Crys, respectively, 
which was over three fold increase to previous batches. In cytotoxicity test there 
was no notable difference in cell densities between controls (glass slide, gelatin, 
BSA) and silk films, indicating absence of cytotoxicity in any of the silk constructs. 
The cell viability test showed increase in absorbance, i.e. viability, when moving 
from CBM terminals to crystallin, which was in accord with the hypothesis. Cell 
viability with Crys-ADF3-FB_H-Crys was higher than gelatin in all tests 
(significant in half of the tests, α=0.05), which is very promising considering that 
gelatin is partly hydrolyzed collagen, the main component of fibroblast ECM. In 
cell adhesion assays the adhesion was not notably different between CBM-ADF3-
CBM and CBM-ADF3-FB_H-Crys, indicating that the adhesion site was not 
accessible or compatible with HDF. The adhesion was increased significantly in 
Crys-ADF3-FB_H-Crys, but it is unknown whether this comes from better 
accessibility to the site or from the presence of crystallin. Unlike in cell viability 
tests, gelatin achieved higher results than Crys-ADF3-FB_H-Crys, assumedly 
because of the fibroblast adhesion sites.  
The FTIR analysis of silk films showed high structural similarity between the silk 
constructs, albeit with some differences in relative peak intensities and absence of 
clear amide III peak in CBM-ADF3-CBM. Contact angle measurements were 
performed with and without ventilation during 2-hour incubation of the protein 
films followed by aspiration of the remaining solution, where the latter mimics the 
coating of 96-well plate. Surprisingly, contact angles of the silk constructs were 
mostly very hydrophobic (112.0-130.5°), with exception of ventilated CBM-ADF3-
CBM silk films (21.0-54.2°). The results suggest that the high hydrophobicity came 
from ADF3, and at least with CBM-ADF3-CBM the hydrophobicity could be 
altered drastically by increasing protein layer thickness and/or slowly evaporating 
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the water. While the causes of these results are unknown, one explanation could be 
that the hydrophobic alanine blocks of ADF3 stacked at the surface forming a 
hydrophobic layer due to slow evaporation of water that forced the hydrophilic 
(amorphous) regions to group together. 
The aim of this thesis was to evaluate cytotoxicity and biocompatibility of ADF3 
fusion proteins and draw conclusions about structure-function relationship, and 
compare the silk materials to conventional materials. These goals were achieved. 
However, the given silk constructs and methods were not enough to fully explain 
the structure-function relationship of CBM/crystallin and heparin cell adhesion site 
to biocompatibility. For future work, silk constructs, such as CBM-ADF3-FB_H-
CBM, CBM-ADF3-Crys and Crys-ADF3-Crys could answer these questions. Also, 
silk construct with fibronectin domains, culturing with stem cell lines and 
modification of silk films with kosmotropic salts could be used to widen the 
research.  
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Attachment 2. SEM: Fibroblast culture on glass. 
 
  
 
Attachment 3. SEM: Fibroblast culture on CMB-ADF3-CBM film. 
 
Attachment 4. FTIR spectra of CBM-ADF3-CBM film. Absorbance has been 
normalized. Recognized structural peaks: amide I ~1640 cm-1, amide II ~1520 cm-1, 
amide III ~1250-1240 cm-1. Other peaks: water 3500-3000 cm-1 and TRIS ~1045 
cm-1. 
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Attachment 5. FTIR spectra of CBM-ADF3-FB_H-Crys film. Absorbance has been 
normalized. Recognized structural peaks: amide I ~1640 cm-1, amide II ~1520 cm-1, 
amide III ~1250-1240 cm-1. Other peaks: water 3500-3000 cm-1 and TRIS ~1045 
cm-1. 
 
Attachment 6. FTIR spectra of Crys-ADF3-FB_H-Crys film. Absorbance has been 
normalized. Recognized structural peaks: amide I ~1640 cm-1, amide II ~1520 cm-1, 
amide III ~1250-1240 cm-1. Other peaks: water 3500-3000 cm-1 and TRIS ~1045 
cm-1. 
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